All of these results indicated that TUG1 overexpression alleviated TAC‐induced cardiac hypertrophy and dysfunction through TUG1/miR‐34a/DKK1/Wnt‐β‐catenin signalling in vivo. This evidence concerns the gene TUG1 and cardiac hypertrophy.